Augustine Therapeutics

Leuven, Belgium · Founded 2019 · Privately Held (backing)

Developer of therapeutic drugs designed to treat neuromuscular and neurodegenerative diseases. Augustine Therapeutics is based in Leuven, Belgium and was founded in 2019. Its last reported valuation was $73.5 million in Mar 2025. It has raised $93.4 million.

Last reported valuation
$73.5M
Oct 2026
Priced at
—
Total raised
$93.4M
Last round
—

Who backs Augustine Therapeutics?

14 investors
InvestorType
Novo HoldingsOther
Participatiemaatschappij VlaanderenOther
Asabys PartnersVenture capital
Eli Lilly and Company FoundationOther
VIBOther
AdBio partners—
CMT Research Foundation—
Eli Lilly—
Jeito—
KU Leuven—
+ 4 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Augustine Therapeutics investors

14 investors are on record for Augustine Therapeutics, including Novo Holdings, Participatiemaatschappij Vlaanderen, Asabys Partners and Eli Lilly and Company Foundation.

Free account
More of Augustine Therapeutics with a free account
  • ·The complete investor list: 14 names
  • ·Watch Augustine Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 14 firms already write checks for companies like Augustine Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View